Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Total Debt: 2019-2025

Historic Total Debt for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $168.5 million.

  • Harmony Biosciences Holdings' Total Debt fell 7.84% to $168.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $168.5 million, marking a year-over-year decrease of 7.84%. This contributed to the annual value of $179.3 million for FY2024, which is 7.39% down from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Total Debt stood at $168.5 million for Q3 2025, which was down 2.09% from $172.1 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Total Debt peaked at $197.1 million during Q3 2023, and registered a low of $168.5 million during Q3 2025.
  • In the last 3 years, Harmony Biosciences Holdings' Total Debt had a median value of $186.4 million in 2024 and averaged $184.4 million.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Total Debt rose by 2.82% in 2023 and then dropped by 7.84% in 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Total Debt (Quarterly) stood at $192.0 million in 2021, then decreased by 0.18% to $191.6 million in 2022, then grew by 1.00% to $193.6 million in 2023, then declined by 7.39% to $179.3 million in 2024, then dropped by 7.84% to $168.5 million in 2025.
  • Its last three reported values are $168.5 million in Q3 2025, $172.1 million for Q2 2025, and $175.7 million during Q1 2025.